Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience.
Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Motl R, Rocca MA, Sandroff BM, Salter A; CogEx Research Team. Feinstein A, et al. Among authors: salter a. J Neurol. 2022 Apr;269(4):1758-1763. doi: 10.1007/s00415-021-10881-3. Epub 2021 Nov 5. J Neurol. 2022. PMID: 34741240 Free PMC article.
Break in binocular fusion during head turning in MS patients with INO.
Mills DA, Frohman TC, Davis SL, Salter AR, McClure S, Beatty I, Shah A, Galetta S, Eggenberger E, Zee DS, Frohman EM. Mills DA, et al. Among authors: salter ar. Neurology. 2008 Aug 5;71(6):458-60. doi: 10.1212/01.wnl.0000324423.08538.dd. Neurology. 2008. PMID: 18678831 No abstract available.
Reproducibility of optical coherence tomography in multiple sclerosis.
Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA. Cettomai D, et al. Among authors: salter a. Arch Neurol. 2008 Sep;65(9):1218-22. doi: 10.1001/archneur.65.9.1218. Arch Neurol. 2008. PMID: 18779426
Retinal architecture predicts pupillary reflex metrics in MS.
Salter AR, Conger A, Frohman TC, Zivadinov R, Eggenberger E, Calabresi P, Cutter G, Balcer L, Frohman EM. Salter AR, et al. Mult Scler. 2009 Apr;15(4):479-86. doi: 10.1177/1352458508100503. Epub 2008 Dec 17. Mult Scler. 2009. PMID: 19091882
Factors that influence adherence with disease-modifying therapy in MS.
Treadaway K, Cutter G, Salter A, Lynch S, Simsarian J, Corboy J, Jeffery D, Cohen B, Mankowski K, Guarnaccia J, Schaeffer L, Kanter R, Brandes D, Kaufman C, Duncan D, Marder E, Allen A, Harney J, Cooper J, Woo D, Stüve O, Racke M, Frohman EM. Treadaway K, et al. Among authors: salter a. J Neurol. 2009 Apr;256(4):568-76. doi: 10.1007/s00415-009-0096-y. Epub 2009 Apr 27. J Neurol. 2009. PMID: 19444532
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).
Remington GM, Treadaway K, Frohman T, Salter A, Stüve O, Racke MK, Hawker K, Agosta F, Sormani MP, Filippi M, Frohman EM. Remington GM, et al. Among authors: salter a. Ther Adv Neurol Disord. 2010 Jan;3(1):3-13. doi: 10.1177/1756285609355851. Ther Adv Neurol Disord. 2010. PMID: 21180632 Free PMC article.
Got milk?
Cutter G, Salter A. Cutter G, et al. Among authors: salter a. Ann Neurol. 2011 Jul;70(1):3-4. doi: 10.1002/ana.22507. Ann Neurol. 2011. PMID: 21786294 No abstract available.
470 results